![]() |
Volumn 294, Issue 5544, 2001, Pages 1021-1024
|
A paradigm shift in brain research
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELLS;
NEUROLOGY;
CENTRAL NERVOUS SYSTEMS;
CHEMICAL SIGNALLING;
BRAIN;
3 [3 (METHYLSULFONYL)PHENYL] 1 PROPYLPIPERIDINE;
ANTIHISTAMINIC AGENT;
ANTIPARKINSON AGENT;
DIPHENHYDRAMINE;
DOPAMINE;
DOPAMINE RECEPTOR BLOCKING AGENT;
FLUOXETINE;
LEVODOPA;
NORADRENALIN;
PHENIRAMINE;
RESERPINE;
SEROTONIN UPTAKE INHIBITOR;
ZIMELDINE;
BIOCHEMISTRY;
ANXIETY NEUROSIS;
BRAIN DISEASE;
CENTRAL NERVOUS SYSTEM DISEASE;
DEPRESSION;
DOPAMINERGIC SYSTEM;
DYSTONIA;
HUMAN;
MENTAL DISEASE;
NERVE CELL;
NEUROLOGIC DISEASE;
NEUROPHARMACOLOGY;
NEUROTRANSMISSION;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
PSYCHOTHERAPY;
REVIEW;
SCHIZOPHRENIA;
SEROTONINERGIC TRANSMISSION;
SIDE EFFECT;
ANIMALS;
ANTIPSYCHOTIC AGENTS;
BRAIN;
BRAIN DISEASES;
CEREBRAL CORTEX;
CORPUS STRIATUM;
DOPAMINE;
HUMANS;
LEVODOPA;
MENTAL DISORDERS;
NEUROTRANSMITTER AGENTS;
SYNAPTIC TRANSMISSION;
THALAMUS;
ZIMELDINE;
|
EID: 0035798328
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1066969 Document Type: Review |
Times cited : (172)
|
References (44)
|